OKYO Pharma OKYO
NASDAQ OKYO
$1.44 -0.10 (-6.49%)
As of: Oct 22, 2026 · 12:05 PM EDT

OKYO Pharma (OKYO) Invested Capital (2023 - 2025)

Updated

OKYO Pharma (OKYO) reported Invested Capital of $161,874 for the year ended Mar 31, 2023.

Analysis

OKYO Pharma (OKYO) Invested Capital (2023 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Eli Lilly 1,171.71 Bn 1,140.30 Bn 19.71 Bn 88.79 Bn
2 Johnson & Johnson 642.13 Bn 560.65 Bn 17.26 Bn 134.01 Bn
3 AbbVie 501.64 Bn 474.75 Bn 12.70 Bn 64.89 Bn
4 Merck 375.66 Bn 330.04 Bn 12.21 Bn 95.89 Bn
5 Novartis Ag 302.79 Bn 266.78 Bn 11.24 Bn 51.53 Bn
6 Astrazeneca 268.68 Bn 242.37 Bn 12.86 Bn 82.72 Bn
7 Amgen 242.43 Bn 197.83 Bn 7.24 Bn 68.99 Bn
8 Gilead Sciences 193.69 Bn 167.89 Bn 6.22 Bn 38.08 Bn
9 Pfizer 172.47 Bn 119.12 Bn 10.94 Bn 148.69 Bn
10 OKYO Pharma 968.79 Mn 942.01 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -3.23 Mn
Sep 30, 2024 -7.22 Mn
Sep 30, 2023 -3.56 Mn
Mar 31, 2023 161,874.00
API Access

OKYO Pharma Invested Capital API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=invested-capital&ticker=OKYO&period=max&api_key=YOUR_API_KEY